Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from Nanosonics Limited ( (AU:NAN) ) is now available.
Nanosonics Limited has provided an update on its ongoing on-market share buy-back program for its ordinary fully paid shares. The company reported that as of 16 April 2026 it had repurchased a cumulative 4,707,341 shares before the previous trading day, and bought back an additional 100,000 shares on the previous day.
The latest daily notification reflects continued execution of the buy-back first announced in December 2025. This steady pace of repurchases signals active capital management and may support earnings per share and share price over time, with implications for existing shareholder ownership and market liquidity.
The most recent analyst rating on (AU:NAN) stock is a Buy with a A$5.55 price target. To see the full list of analyst forecasts on Nanosonics Limited stock, see the AU:NAN Stock Forecast page.
More about Nanosonics Limited
Nanosonics Limited is an Australia-listed medical technology company, trading under the ASX code NAN. It issues ordinary fully paid shares and operates in the healthcare sector, where capital management initiatives such as on-market share buy-backs are used to optimise its balance sheet and shareholder returns.
Average Trading Volume: 784,392
Technical Sentiment Signal: Sell
Current Market Cap: A$1.07B
For a thorough assessment of NAN stock, go to TipRanks’ Stock Analysis page.